insulin and glp-1 agonist combination Clinical Focus on Agonists in Type 2 Diabetes Mellitus New Developments in Pharmacological Treatment

Zepbound shows superior weight loss results.

From a scientific breakthrough studying the oft fasting Gila Monster has become the current successful weight loss therapies, here's how.

Explore a thorough comparison of Semaglutide and other GLP-1 receptor agonists

For external use only

Methods Adults (18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index